Aspen Aerogels Inc. (ASPN) Given Average Recommendation of “Buy” by Analysts
Aspen Aerogels Inc. (NYSE:ASPN) has earned an average rating of “Buy” from the seven ratings firms that are currently covering the stock. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $7.70.
ASPN has been the subject of several recent analyst reports. Canaccord Genuity reaffirmed a “buy” rating on shares of Aspen Aerogels in a research report on Wednesday, June 22nd. Citigroup Inc. lowered their price target on Aspen Aerogels from $6.50 to $6.00 and set a “buy” rating for the company in a research report on Thursday, July 7th. Zacks Investment Research raised Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Monday, July 11th. JPMorgan Chase & Co. lowered their price target on Aspen Aerogels from $8.00 to $7.00 and set an “overweight” rating for the company in a research report on Friday, August 5th. Finally, Craig Hallum initiated coverage on Aspen Aerogels in a research report on Tuesday, September 20th. They issued a “buy” rating and a $10.00 price target for the company.
In other Aspen Aerogels news, Director Mark L. Noetzel acquired 13,576 shares of Aspen Aerogels stock in a transaction that occurred on Tuesday, August 9th. The stock was bought at an average cost of $4.74 per share, for a total transaction of $64,350.24. Following the acquisition, the director now owns 36,178 shares of the company’s stock, valued at $171,483.72. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director William P. Noglows acquired 20,000 shares of Aspen Aerogels stock in a transaction that occurred on Wednesday, August 24th. The stock was acquired at an average price of $4.98 per share, with a total value of $99,600.00. Following the completion of the acquisition, the director now directly owns 46,178 shares in the company, valued at approximately $229,966.44. The disclosure for this purchase can be found here. 14.70% of the stock is owned by corporate insiders.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/11/aspen-aerogels-inc-aspn-given-average-recommendation-of-buy-by-analysts.html
A number of large investors have recently added to or reduced their stakes in the company. Balter Liquid Alternatives LLC increased its stake in Aspen Aerogels by 162.8% in the first quarter. Balter Liquid Alternatives LLC now owns 33,236 shares of the company’s stock valued at $150,000 after buying an additional 20,590 shares during the last quarter. Firsthand Capital Management Inc. increased its stake in Aspen Aerogels by 16.7% in the second quarter. Firsthand Capital Management Inc. now owns 35,000 shares of the company’s stock valued at $174,000 after buying an additional 5,000 shares during the last quarter. GSA Capital Partners LLP increased its stake in Aspen Aerogels by 71.6% in the second quarter. GSA Capital Partners LLP now owns 44,129 shares of the company’s stock valued at $219,000 after buying an additional 18,419 shares during the last quarter. Palisade Capital Management LLC NJ acquired a new stake in Aspen Aerogels during the first quarter valued at approximately $221,000. Finally, Spark Investment Management LLC increased its stake in Aspen Aerogels by 295.0% in the second quarter. Spark Investment Management LLC now owns 55,700 shares of the company’s stock valued at $276,000 after buying an additional 41,600 shares during the last quarter. Institutional investors own 76.10% of the company’s stock.
Aspen Aerogels (NYSE:ASPN) traded up 1.7250% during midday trading on Tuesday, reaching $6.2154. 22,411 shares of the company’s stock traded hands. Aspen Aerogels has a one year low of $3.38 and a one year high of $8.87. The stock’s 50 day moving average price is $5.27 and its 200-day moving average price is $4.76. The stock’s market cap is $127.93 million.
Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, August 4th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.02. The firm earned $27.70 million during the quarter, compared to analyst estimates of $30.99 million. Aspen Aerogels had a negative return on equity of 3.35% and a negative net margin of 3.14%. During the same quarter in the previous year, the firm earned ($0.12) EPS. Equities analysts predict that Aspen Aerogels will post ($0.31) earnings per share for the current year.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
Receive News & Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related companies with MarketBeat.com's FREE daily email newsletter.